Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.
With more than a decade of experience in the engineering of cell lines, Horizon offers innovative tools and services based upon the ability to modulate, or permanently alter, the function of almost any gene in human and other mammalian cell lines.
Horizon is headquartered in Cambridge, UK with offices in USA and Japan.
|
|
|
51-200 employees
View all Horizon Discovery employees
|
|
Biotechnology
|
|
8100 Cambridge Research Park, Waterbeach, Cambridge, Cambridgeshire CB25 9TL, GB
|
|
2005
|
|
Rna, Molecular Diagnostics, Sirna, Crispr, Mirna, Gene Editing, Cell Based Assays, Cell Line Engineering, Cell Lines, Shrna, Bioproduction Cell Lines, Crispr Reagents, Crispra, Crispri, Custom Rna Synthesis, Edited Cho Cells, Functional Genomic Screening, Gene Modulation, Reference Standards, T Cell Screening, Noncoding Rna
|
The decision makers in Horizon Discovery are Anna Copping, Dennis France, Jesus Zurdo, etc. Click to Find Horizon Discovery decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.